GlobalData on MSN4mon
Pfizer to withdraw sickle cell treatment OXBRYTA from market
Pfizer has announced the voluntary withdrawal of all lots of OXBRYTA (voxelotor) approved for treating sickle cell disease ...
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
The pharmaceutical giant last week announced it would voluntarily withdraw its sickle cell disease therapy, Oxbryta, from ...
pharmaphorum4mon
Pfizer pulls sickle cell med Oxbryta off market after deaths
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
pharmaphorum3d
Price cut unlocks NHS use of sickle cell drug Oxbryta
It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after an agreement was reached ...
Law1mon
Pfizer Faces Multiple Lawsuits Over Recalled Sickle-Cell Medication
Takeaway: The suit is the latest in a string of suits filed following the recall of Oxbryta, a drug used to treat sickle-cell disease. Lawyers: Marcus J. Bradley and Kiley Lynn Grombacher of ...